Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

Summary

This study is a exploratory comparison of the efficacy and safety of paricalcitol injection with maxacalcitol injection in chronic kidney disease participants receiving hemodialysis with secondary hyperparathyroidism.

Timeline

Start

2009-10

Primary completion

2010-05

Completion

2010-05

Outcome

Missed primary endpoint

registry p = 0.518; Difference between arms in percentage 13.6 (95% CI -22.36 to 49.63); Fisher Exact NCT00990704 ↗

Drugs

Indications